Topline results from the SURPASS-ET trial: ropeginterferon alfa-2b versus anagrelide in ET

106 views

VJHemOnc – Video Journal of Hematology & HemOnc

4 months ago

Topline results from the SURPASS-ET trial: ropeginterferon alfa-2b versus anagrelide in ET

Topline results from the SURPASS-ET trial: ropeginterferon alfa-2b versus anagrelide in ET